Personalis Receives Medicare Coverage for NeXT Personal in Lung Cancer Surveillance
The NeXT Personal molecular residual disease test can now be used for surveillance of patients with Stage I to III non-small cell lung cancer.
Category: Lung Cancer
Lung Cancer
Latest
Lung Cancer
Latest
Circulating Tumor DNA Shows Promise for Guiding Immunotherapy in Lung Cancer
Study of 177 patients with limited-stage small cell lung cancer demonstrates ctDNA's potential to personalize consolidation immunotherapy decisions.
Lung Cancer
Latest
Lung Cancer Detection May Have Gotten Easier
Scientists have developed a low-cost, fast-response sensor capable of detecting lung cancer biomarkers from a blood sample in just 40 minutes.
Roche and Sheba Medical Center Partner to Improve NSCLC Diagnosis Using AI-Powered Digital Pathology
Roche and Sheba Medical Center’s ARC are collaborating to enhance NSCLC diagnosis and treatment using AI-driven digital pathology tools.
Read More
Mesothelioma Cancer Detection May Improve with New Test
Researchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read More
Nanowire-Based Urine Test with AI Detects Early-Stage Lung Cancer with High Accuracy
Researchers developed a non-invasive cancer detection tool using nanowire-based miRNA extraction and AI to identify lung cancer in urine.
Read More
New Blood Test Detects Drug-Induced Tissue Damage in Cancer Patients Early
A blood test identifies early lung damage in cancer patients taking antibody–drug conjugates, offering an alternative to imaging scans.
Read More
Researchers Develop Robotic Sensory Cilia that Detect Airway Diseases
The system enables detection and personalized care for diseases like Cystic Fibrosis, Chronic Obstructive Pulmonary Diseases, and lung cancer.
Read More
Detecting Evidence of Lung Cancer in Exhaled Breath
Researchers developed a sensor that can detect low levels of isoprene in exhaled breath, potentially enabling early lung cancer diagnosis.
Read More
NeoGenomics’ Solid Tumor Test Gets New York State Approval
NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.
Read More
BioAffinity Awarded US Federal Supply Schedule Contract for Noninvasive Lung Test
BioAffinity Technologies’ noninvasive lung cancer test is available to Veterans and military personnel for early-stage lung cancer detection.
Read More
Breakthrough Lung Cancer Blood Test is 14 Times More Sensitive
A new microchip uses exosome analysis to detect lung cancer from a simple blood draw, enhancing speed and sensitivity in cancer diagnostics.
Read More
PathAI Adds MET Predict to AISight for NSCLC Assessments
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Read More
DELFI Diagnostics Taps New CFO
Summary: DELFI Diagnostics appointed Thomas Russo as its new CFO to support the company’s...
Read More
AI-Powered Digital Pathology Platform Aids Lung Cancer Diagnosis
A new AI-driven digital pathology platform enables fully automated, rapid, and accurate analysis of lung cancer tissue.
Read More
Open Comment Period to Revise Molecular Testing Guidelines in Lung Cancer Treatment Announced
Several diagnostic associations announced the open comment period for the revised 2018 guideline on molecular testing for lung cancer.
Read More
New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients
A new study from OncoHost reveals that its PROphetNSCLC test impacts oncologists’ first-line treatment decisions for metastatic NSCLC.
Read More
Development of Breath Test for Lung Disease is Underway
Researchers have developed a potential exhaled-breath test for lung diseases by successfully collecting lung biomarkers from human breath.
Read More